Back to 
DRIEHAUS CAPITAL MANAGEMENT LLCCMCMTA
DRIEHAUS CAPITAL MANAGEMENT LLCCMCMTA2 quarters
Position history for DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in Clementia Pharmaceuticals Inc.
No. Driehaus Capital Management exited its CMTA (Clementia Pharmaceuticals) position in Q2 2019. Its Q1 2019 13F listed 408,553 shares worth $10.7M. Driehaus Capital Management already held CMTA in its Q1 2019 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$10.7M
Total Shares Change
-408,553
Quarter-by-Quarter History
Other major holders of CMTA: BAKER BROS. ADVISORS LP, Alyeska Investment Group, L.P., TUDOR INVESTMENT CORP ET AL, FEDERATED HERMES, INC., MILLENNIUM MANAGEMENT LLC